Prothena

Bristol Myers Squibb checks 'yes' on another Prothena neurodegenerative therapy
Fierce Biotech
Wed, 05/29/24 - 09:30 pm
Bristol Myers Squibb
Prothena
neurodegenerative disease
PRX019
BMS makes quickfire bets on neurodegeneration, paying $95M to exercise Evotec, Prothena options
Fierce Biotech
Tue, 07/11/23 - 10:13 am
Bristol Myers Squibb
neurodegenerative disease
Prothena
Alzheimer's disease
Evotec
Unpartnered assets: on the shelf or hidden treasure?
EP Vantage
Thu, 06/15/23 - 09:54 am
R&D
ALX Oncology
Argenx
Ascendis Pharma
Cytokinetics
Karuna Therapeutics
Madrigal Pharmaceuticals
Protagonist Therapeutics
Prothena
Ultragenyx Pharmaceutical
Unique Pharma
Ventyx Biosciences
Prothena leverages Walgreens’ capabilities to accelerate development of Alzheimer’s Drug
Medical Marketing and Media
Sun, 04/16/23 - 11:15 pm
Prothena
PRX012
fast track
Walgreens
clinical trials
FDA grants Prothena fast track designation for Alzheimer’s disease therapy
Biopharma Reporter
Tue, 05/3/22 - 10:46 am
Prothena
FDA
fast track
Alzheimer's status
PRX012
Biopharma’s stock market winners of 2021 revealed
EP Vantage
Wed, 01/12/22 - 10:50 am
biotech stocks
Eli Lilly
Pfizer
Abbott Labs
Moderna Therapeutics
Merck KGaA
Novo Nordisk
BioNTech
Biohaven
Prothena
Bicycle Therapeutics
Bellus Health
Evolus
Prothena rolls out preclinical data for anti-amyloid Alzheimer's candidate to rival Biogen's Aduhelm
Fierce Biotech
Mon, 07/26/21 - 10:09 pm
Prothena
Alzheimer's disease
monoclonal antibodies
Biogen
Aduhelm
PRX012
Novo Nordisk puts $1.2B on the table for Prothena’s ATTR drug, teeing up Alnylam challenge and cardiovascular expansion
Fierce Biotech
Mon, 07/12/21 - 10:40 am
Novo Nordisk
Prothena
ATTR amyloidosis
PRX004
With Alzheimer's drugs in focus, Bristol Myers rejoins the hunt
BioPharma Dive
Thu, 06/24/21 - 12:35 pm
Bristol Myers Squibb
Prothena
Alzheimer's disease
PRX005
A busy year ahead for Parkinson’s disease
EP Vantage
Wed, 03/3/21 - 10:56 am
Parkinson's Disease
drug development
AstraZeneca
Roche
Prothena
MeiraGTx
Annovis Bio
Sanofi
Alkahest
Peptron
SAGE Therapeutics
Prothena revives its former lead drug, aiming for a smaller population with more severe cases
Endpoints
Wed, 02/3/21 - 10:59 pm
Prothena
NEOD001
clinical trials
AL amyloidosis
Roche buys into Prothena... kind of
EP Vantage
Wed, 10/21/20 - 10:39 am
Roche
Prothena
prasinezumab
Parkinson's Disease
Smaller groups await Bristol-Myers Squelgene fallout
EP Vantage
Wed, 01/16/19 - 11:53 am
M&A
Bristol-Myers Squibb
Celgene
Vividion Therapeutics
Evotec
Prothena
Anokion
Skyhawk Therapeutics
Dragonfly Therapeutics
BeiGene
Agios Pharmaceuticals
Jounce Therapeutics
The 3 Worst Biotech Stocks of 2018 (So Far)
Motley Fool
Sun, 07/8/18 - 12:35 pm
biotech
Prothena
Tesaro
Acadia
After AL amyloidosis flop, Prothena slashes workforce by 57%
Fierce Biotech
Fri, 05/25/18 - 10:08 am
Prothena
R&D
Celgene
AL amyloidosis
layoffs
Prothena’s lead drug NEOD001 just imploded in 2 late-stage studies — and there’s nothing left to salvage
Endpoints
Mon, 04/23/18 - 09:14 am
Prothena
AL amyloidosis
clinical trials
NEOD001
Prothena, Celgene ink neuro R&D pact potentially worth $2B+
Fierce Biotech
Wed, 03/21/18 - 09:20 am
Prothena
Celgene
R&D
TDP-43
anti-tau antibodies
Alzheimer's disease
Parkinson's Now a Hot Therapeutic Area: What's Up Lately?
Yahoo/Zacks.com
Sat, 09/2/17 - 11:11 am
Parkinson's Disease
Novartis
Teva Pharmaceutial
UCB Pharma
MEDI1341
AstraZeneca
Takeda
PRX002
Prothena
Roche
Acorda
Inbrija
Adamas Pharmaceuticals
Gocovri
These 15 Biotech Companies Could Be Takeover Targets
Barron's
Wed, 06/29/16 - 12:56 pm
biotech
M&A
Alder Biopharmaceuticals
Biomarin
Coherus Biosciences
Intercept Pharma
Ultragenyx
Seattle Genetics
Adamas Pharmaceuticals
Alexion
Clovis Oncology
Corbus Pharmaceuticals
Incyte
Prothena
Puma Biotechnology
Tesaro
Versartis
Biotech: Is the Rally Real?
Barron's
Thu, 06/2/16 - 04:01 pm
biotech
Prothena
Biomarin
Vertex Pharmaceuticals
Incyte
Celgene

Pages